P&G Q4 FY26 GAAP diluted EPS drops 15% to $1.26; net sales rise 2% to $21.2 billion
PG•FY2027 outlook and management comments
- P&G guided FY2027 net sales growth of 1%-3% with diluted EPS growth of 1%-5% from USD 6.62.
- CEO Shailesh Jejurikar said FY2026 built foundations, with plans to accelerate growth semester-to-semester in FY2027 via productivity-funded investment.
Quarterly results and full-year performance
- Procter & Gamble Q4 FY2026 diluted EPS fell 15% to USD 1.26 as net sales rose 2% to USD 21.2 billion.
- Core EPS (non-GAAP) dipped 3% to USD 1.43; GAAP net earnings slid 15% to USD 3.08 billion.
- FY2026 diluted EPS rose 2% to USD 6.62 as net sales increased 3% to USD 87 billion.
Related News
Cenovus raises 2026 production outlook as quarterly profit more than triples
CVE•
MGP Ingredients Q2 FY26 net income falls 16.67% to US$ 12 million; net sales drop 15% to US$ 124.4 million
MGPI•
